Inspire Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Inspire Pharmaceuticals, Inc..The latest application filed is for "method for treating blepharitis".

Company Profile

0.89.12

Inspire Pharmaceuticals, Inc. - Durham NC
INSPIRE PHARMACEUTICALS, INC. - Whitehouse Station NJ
Inspire Pharmaceuticals, Inc. - N/A
Inspire Pharmaceuticals, Inc. - Burham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,218 - Lampe , et al. December 10, 2	2013-12-10
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,205 - Lampe , et al. December 10, 2	2013-12-10
Method For Treating Blepharitis App 20130274214 - Brubaker; Kurt E.	2013-10-17
Method For Treating Cardiovascular Diseases Using Rho Kinase Inhibitor Compounds App 20130172324 - LAMPE; John W. ; et al.	2013-07-04
Method For Treating Diseases Associated With Alterations In Cellular Integrity Using Rho Kinase Inhibitor Compounds App 20130158014 - PETERSON; Ward M. ; et al.	2013-06-20
Bifunctional Rho Kinase Inhibitor Compounds, Composition And Use App 20130131106 - LAMPE; John W. ; et al.	2013-05-23
Method For Treating Ophthalmic Diseases Using Kinase Inhibitor Compounds In Prodrug Forms App 20130131059 - LAMPE; John W. ; et al.	2013-05-23
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds Grant 8,410,147 - Peterson , et al. April 2, 2	2013-04-02
Method of treating blepharitis Grant 8,349,806 - Brubaker , et al. January 8, 2	2013-01-08
Method for treating pulmonary diseases using rho kinase inhibitor compounds Grant 8,299,096 - Navratil , et al. October 30, 2	2012-10-30
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds Grant 8,207,195 - Navratil , et al. June 26, 2	2012-06-26
Method for treating cystic fibrosis Grant 8,168,597 - Kellerman , et al. May 1, 2	2012-05-01
P2Y.sub.6 receptor agonists for treating lung diseases Grant 8,158,776 - Boyer , et al. April 17, 2	2012-04-17
Process for the preparation of Rho-kinase inhibitor compounds Grant 8,158,796 - She , et al. April 17, 2	2012-04-17
Method of increasing tear production with purinergic receptor agonists Grant 8,097,600 - Yerxa , et al. January 17, 2	2012-01-17
Medicine Dispenser App 20120000936 - Krishnamoorthy; Ramesh	2012-01-05
Medicine Dispenser App 20120000941 - Krishnamoorthy; Ramesh ; et al.	2012-01-05
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,071,779 - Lampe , et al. December 6, 2	2011-12-06
Cytoskeletal active compounds, composition and use Grant 8,039,465 - Lampe , et al. October 18, 2	2011-10-18
P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis Grant 8,008,274 - Yerxa , et al. August 30, 2	2011-08-30
Medicine dispenser Grant D640,554 - Krishnamoorthy June 28, 2	2011-06-28
Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones Grant 7,947,850 - DeCamp , et al. May 24, 2	2011-05-24
Non-nucleotide composition for inhibiting platelet aggregation Grant 7,943,760 - Plourde, Jr. , et al. May 17, 2	2011-05-17
Di(uridine 5'-)tetraphosphate and salts thereof Grant 7,939,510 - Yerxa , et al. May 10, 2	2011-05-10
Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation Grant 7,932,376 - Douglass, III , et al. April 26, 2	2011-04-26
P2Y6 receptor agonists for treating lung diseases Grant 7,851,456 - Boyer , et al. December 14, 2	2010-12-14
Pharmaceutical latrunculin formulations Grant 7,785,624 - Krishnamoorthy , et al. August 31, 2	2010-08-31
Method of treating dry eye disease with purinergic receptor agonists Grant 7,759,322 - Yerxa , et al. July 20, 2	2010-07-20
Non-nucleotide compositions and method for treating pain Grant 7,749,980 - Plourde, Jr. , et al. July 6, 2	2010-07-06
Drug-eluting stents coated with non-nucleotide P2Y.sub.12 receptor antagonist compound Grant 7,749,981 - Boyer , et al. July 6, 2	2010-07-06
Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles Grant 7,741,473 - Watson , et al. June 22, 2	2010-06-22
Cytoskeletal active compounds, composition and use Grant 7,666,861 - Lampe , et al. February 23, 2	2010-02-23
Drug-eluting stents coated with P2Y.sub.12 receptor antagonist compound Grant 7,618,949 - Boyer , et al. November 17, 2	2009-11-17
Degradation-resistant mononucleoside phosphate compounds Grant 7,612,047 - Douglass, III , et al. November 3, 2	2009-11-03
Non-nucleotide composition and method for inhibiting platelet aggregation Grant 7,592,445 - Plourde, Jr. , et al. September 22, 2	2009-09-22
P.sup.1-(2'-deoxycytidine 5'-)P.sup.4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis Grant 7,531,525 - Yerxa , et al. May 12, 2	2009-05-12
Di(uridine 5'-)tetraphosphate and salts thereof Grant 7,528,119 - Yerxa , et al. May 5, 2	2009-05-05
Orally bioavailable compounds and methods for inhibiting platelet aggregation Grant 7,504,497 - Douglass, III , et al. March 17, 2	2009-03-17
Drug-eluting stents coated with P2Y.sub.12 receptor antagonist compound Grant 7,452,870 - Boyer , et al. November 18, 2	2008-11-18
Method of promoting cervical and vaginal secretions Grant 7,432,252 - Pendergast , et al. October 7, 2	2008-10-07
Method Of Promoting Cervical And Vaginal Secretions App 20080214490 - Pendergast; William ; et al.	2008-09-04
Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones Grant 7,414,137 - DeCamp , et al. August 19, 2	2008-08-19
Method for treating allergic rhinitis without adverse effects Grant 7,378,082 - Krishnamoorthy May 27, 2	2008-05-27
Non-nucleotide compositions and method for inhibiting platelet aggregation Grant 7,368,438 - Plourde, Jr. , et al. May 6, 2	2008-05-06
Non-nucleotide composition and method for inhibiting platelet aggregation Grant 7,335,648 - Plourde, Jr. , et al. February 26, 2	2008-02-26
Cytoskeletal active compounds, compositions and use Grant 7,320,974 - Lampe , et al. January 22, 2	2008-01-22
Method for treating or preventing inflammatory diseases Grant 7,256,183 - Peterson , et al. August 14, 2	2007-08-14
Method of treating dry eye disease with non-drying antihistamines Grant 7,247,623 - Yerxa , et al. July 24, 2	2007-07-24
Method of enhancing drainage of lacrimal system with purinergic receptor agonists Grant 7,235,535 - Yerxa , et al. June 26, 2	2007-06-26
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof Grant 7,223,744 - Yerxa , et al. May 29, 2	2007-05-29
Composition and method for inhibiting platelet aggregation Grant 7,132,408 - Boyer , et al. November 7, 2	2006-11-07
Di(uridine 5'-)tetraphosphate and salts thereof Grant 7,132,410 - Yerxa , et al. November 7, 2	2006-11-07
Compositions for treating epithelial and retinal tissue diseases Grant 7,115,585 - Yerxa , et al. October 3, 2	2006-10-03
Joint lubrication with P2Y purinergic receptor agonists Grant 7,109,181 - Cowlen , et al. September 19, 2	2006-09-19
Composition and method for inhibiting platelet aggregation Grant 7,101,860 - Boyer , et al. September 5, 2	2006-09-05
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof Grant 7,091,334 - Yerxa , et al. August 15, 2	2006-08-15
Method for reducing intraocular pressure Grant 7,084,128 - Yerxa , et al. August 1, 2	2006-08-01
Method of treating edematous retinal disorders Grant 7,078,391 - Peterson , et al. July 18, 2	2006-07-18
Composition and method for inhibiting platelet aggregation Grant 7,018,985 - Boyer , et al. March 28, 2	2006-03-28
Ectocornea extension promoters Grant 6,984,629 - Nakata , et al. January 10, 2	2006-01-10
Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency Grant 6,977,246 - Pendergast , et al. December 20, 2	2005-12-20
Method of treating dry eye disease with purinergic receptor agonists Grant 6,921,755 - Yerxa , et al. July 26, 2	2005-07-26
Compositions and methods for the treatment of glaucoma or ocular hypertension Grant 6,897,201 - Boyer , et al. May 24, 2	2005-05-24
Method of treating dry eye disease with purinergic receptor agonists Grant 6,887,858 - Yerxa , et al. May 3, 2	2005-05-03
Method for treating pain Grant 6,881,725 - Yerxa , et al. April 19, 2	2005-04-19
Di(uridine 5')-tetraphosphate and salts thereof Grant 6,872,710 - Yerxa , et al. March 29, 2	2005-03-29
Dinucleoside polyphosphate compositions and their therapeutic use Grant 6,867,199 - Rideout , et al. March 15, 2	2005-03-15
Method for treating retinal degeneration with purinergic receptor agonists Grant 6,864,243 - Peterson March 8, 2	2005-03-08
Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate Grant 6,818,629 - Peterson , et al. November 16, 2	2004-11-16
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof Grant 6,765,090 - Yerxa , et al. July 20, 2	2004-07-20
Method for reducing intraocular pressure using indole derivatives Grant 6,730,707 - Pintor , et al. May 4, 2	2004-05-04
Therapeutic uses of di(uridine 5')-tetraphosphate and salts thereof Grant 6,713,458 - Yerxa , et al. March 30, 2	2004-03-30
Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients Grant 6,703,376 - Jacobus , et al. March 9, 2	2004-03-09
Method of treating dry eye disease with purinergic receptor agonists Grant 6,696,425 - Yerxa , et al. February 24, 2	2004-02-24
Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues Grant 6,673,779 - Jacobus , et al. January 6, 2	2004-01-06
Method of treating gastrointestinal tract disease with purinergic receptor agonists Grant 6,624,150 - Yerxa , et al. September 23, 2	2003-09-23
Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema Grant 6,596,725 - Peterson , et al. July 22, 2	2003-07-22
Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists Grant 6,555,675 - Rideout , et al. April 29, 2	2003-04-29
Di-(uridine 5')-tetraphosphate and salts thereof Grant 6,548,658 - Yerxa April 15, 2	2003-04-15
Method of promoting cervical and vaginal secretions Grant 6,462,028 - Pendergast , et al. October 8, 2	2002-10-08
Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof Grant 6,451,288 - Boucher, Jr. , et al. September 17, 2	2002-09-17
Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists Grant 6,448,276 - Yerxa September 10, 2	2002-09-10
Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof Grant 6,436,910 - Yerxa , et al. August 20, 2	2002-08-20
Method of treating otitis media with uridine triphosphates and related compounds Grant 6,423,694 - Drutz , et al. July 23, 2	2002-07-23
Method of treating ciliary dyskinesia with uridine triphosphates and related compounds Grant 6,420,347 - Jacobus , et al. July 16, 2	2002-07-16
Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency Grant 6,348,589 - Pendergast , et al. February 19, 2	2002-02-19
Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof Grant 6,331,529 - Yerxa , et al. December 18, 2	2001-12-18
Therapeutic dinucleotide and derivatives Grant 6,323,187 - Yerxa , et al. November 27, 2	2001-11-27
Method of treating dry eye disease with nicotinic acetylcholine receptor agonists Grant 6,277,855 - Yerxa August 21, 2	2001-08-21
Method of treating bronchitis with uridine triphosphate and related compounds Grant 6,159,952 - Shaffer , et al. December 12, 2	2000-12-12
Uridine 5'-diphosphate and analogs useful for treating lung diseases Grant 6,143,279 - Boucher, Jr. , et al. November 7, 2	2000-11-07
Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof Grant 6,022,527 - Boucher, Jr. , et al. February 8, 2	2000-02-08
Method for treating sinusitis with uridine triphosphates and related compounds Grant 5,981,506 - Jacobus , et al. November 9, 1	1999-11-09
Pharmaceutical compositions of uridine triphosphate Grant 5,968,913 - LaCroix , et al. October 19, 1	1999-10-19
Method of treating sinusitis with uridine triphosphates and related compounds Grant 5,958,897 - Jacobus , et al. September 28, 1	1999-09-28
Method of treating dry eye disease with uridine triphosphates and related compounds Grant 5,900,407 - Yerxa , et al. May 4, 1	1999-05-04
Method of treating sinusitis with uridine triphosphates and related compounds Grant 5,789,391 - Jacobus , et al. August 4, 1	1998-08-04

Company Registrations

NCAGE Code	4WDA6	INSPIRE PHARMACEUTICALS INC.
CAGE Code	4WDA6	INSPIRE PHARMACEUTICALS, INC.
DUNS	926723339	INSPIRE PHARMACEUTICALS, INC.
SEC	0001040416	INSPIRE PHARMACEUTICALS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.